AI Credibility Assessment Toolkit for Regulatory Submissions

Standardizes model-risk and context-of-use evidence packages for AI-enabled submission components Evidence basis: FDA draft guidance introduces a risk-based credibility assessment workflow for AI used in drug and biologic regulatory support; EMA reflection guidance aligns on lifecycle governance transparency and context-specific validation

The Problem

“Standardize AI credibility evidence for pharmaceutical and biotech regulatory submissions”

Organizations face these key challenges:

Credibility evidence is scattered across reports, code repositories, validation documents, and quality records

Context-of-use definitions are inconsistent and often not linked to validation scope

Model-risk assessments vary by team and are difficult to compare across programs

Bias, transparency, and explainability evidence is incomplete or non-standardized

Manual review cycles across regulatory, quality, and technical teams are slow and error-prone

Submission teams struggle to identify missing evidence before dossier finalization

Lifecycle governance updates are not consistently reflected in submission-ready documentation

Impact When Solved

Reduces time to assemble AI credibility evidence packages for submissionsImproves consistency of model-risk classification across therapeutic programsCreates traceable linkage between context of use, validation evidence, and residual riskStrengthens bias, transparency, and lifecycle governance documentationImproves readiness for FDA and EMA review questions and internal audits

The Shift

Before AI~85% Manual

Human Does

•Collect credibility evidence from separate documents and owners
•Review context of use and model-risk information manually
•Coordinate checklist completion and status tracking in spreadsheets
•Identify gaps and request follow-up documentation

Automation

•No AI-driven assessment or prioritization
•No automated evidence packaging or gap detection
•No continuous monitoring of credibility readiness

With AI~75% Automated

Human Does

•Confirm context of use and intended submission scope
•Review prioritized risks, gaps, and recommended actions
•Decide on exceptions, remediation, and evidence sufficiency

AI Handles

•Standardize credibility evidence into a consistent package
•Assess model-risk factors against checklist criteria
•Flag missing, outdated, or inconsistent documentation
•Prioritize high-impact actions for review readiness

Operating Intelligence

How AI Credibility Assessment Toolkit for Regulatory Submissions runs once it is live

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence92%

ArchetypeRecommend & Decide

Shape6-step converge

Human gates1

Autonomy

67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI

2AI

3AI

5AI

gate

Human lead

Approval, override, feedback

4Human

6↺ Loop

AI-led step

Human-controlled step

Feedback loop

TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1AI

Assemble Context

Combine the relevant records, signals, and constraints.

instant

2AI

Analyze

Evaluate options, risk, and likely outcomes.

instant

3AI

Recommend

Present a ranked recommendation with supporting rationale.

instant

4Human checkpoint

Human Decision

A human accepts, edits, or rejects the recommendation.

hours to days

Authority gates · 1

The system must not finalize the context of use or intended submission scope without review by regulatory and quality stakeholders. [S1] [S3]

Why this step is human

The decision carries real-world consequences that require professional judgment and accountability.

5AI

Execute

Carry out the approved action in the operating workflow.

instant

6Feedback

Feedback

Outcome data improves future recommendations.

continuous

1 operating angles mapped

Operational Depth

Technologies

Technologies commonly used in AI Credibility Assessment Toolkit for Regulatory Submissions implementations:

Lifecycle process recordsOther

4 mentions

Quality management documentationOther

4 mentions

Regulatory review workflowOther

4 mentions

AI risk assessment frameworkOther

3 mentions

Performance monitoring planOther

3 mentions

+3 more technologies(sign up to see all)

Key Players

Companies actively working on AI Credibility Assessment Toolkit for Regulatory Submissions solutions:

AI medical device sponsors building responsible AI controls EMA FDA ICH Quality/regulatory platforms for medical AI governance

Real-World Use Cases

Bias and transparency management workflow for AI-enabled medical devices

Before and after launch, the device maker checks whether the AI is fair, explains important information to users, and watches for problems that could hurt certain patient groups.

Fairness-aware classification or prediction with human-facing transparency controlsearly-to-mid stage; fda is formalizing expectations and explicitly seeking comment on adequacy for emerging technologies such as generative ai.

10.0

AI-assisted medicinal product lifecycle decision support

Use AI tools to help people make sense of large amounts of medicine-related data across development, manufacturing, and safety monitoring.

Decision support and pattern extraction from heterogeneous lifecycle dataproposed and actively reflected on by regulators, not presented in the source digest as a single mature deployed system.

9.5